Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2025-12-25 @ 4:47 AM
NCT ID:
NCT05323318
Eligibility Criteria:
Inclusion Criteria:
* ≥18 years;
* Previous COVID-19 at least six months after the diagnosis duly documented in the clinical record;
* Persistent symptoms after cure criteria defined by WHO Symptomatic patients that attend the post-COVID-19 follow-up consultation of the study centres.
* SARS-CoV-2 RNA confirmed by a positive real-time reverse-transcription polymerase chain reaction on a nasopharyngeal swab.
* SARS-CoV-2 antigen confirmed on a nasopharyngeal swab, by a healthcare professional.
Exclusion Criteria:
* Patients with PTSD previous diagnosis
* Severe psychiatric disorders documented in the clinical record
* Patients not able to respond the questionnaire
* Patients who had a concomitant severe neurological disorder
* Clinical and radiological diagnosis of Stroke with sequelae
* Clinical diagnosis of Alzheimer's Disease
* Clinical diagnosis of Parkinson's disease
* Patients with persistent fatigue symptoms in the 6 months before SARS-CoV 2 infection
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
95 Years
Study:
NCT05323318
Study Brief:
Protocol Section:
NCT05323318